Nu-Med Plus, Inc.
NUMD
$0.05
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 63.30K | 109.30K | 107.00K | 114.10K | 120.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 63.30K | 109.30K | 107.00K | 114.10K | 120.50K |
| Operating Income | -63.30K | -109.30K | -107.00K | -114.10K | -120.50K |
| Income Before Tax | -68.40K | -114.40K | -112.10K | -119.10K | -125.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.07 | -0.11 | -0.11 | -0.12 | -0.13 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -68.40K | -114.40K | -112.10K | -119.10K | -125.50K |
| EBIT | -63.30K | -109.30K | -107.00K | -114.10K | -120.50K |
| EBITDA | -- | -54.80K | -69.40K | -91.90K | -118.30K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 336.39M | 328.90M | 328.90M | 328.90M | 326.70M |
| Average Diluted Shares Outstanding | 336.39M | 328.90M | 328.90M | 328.90M | 326.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |